GlassScriptPhysician profile
Hany Ghali
NPI 1790857498
$3,846.27
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,632 · 2020: $1,924 · 2021: $216 · 2022: $73.59.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veran Medical Technologies, INC. | $938.67 | 2020 | |
| Glaxosmithkline, LLC. | $653.10 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $469.48 | 2019-2021 | |
| Philips North America LLC | $381.97 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $243.14 | 2019-2021 | |
| Intuitive Surgical, INC. | $187.86 | 2019 | |
| Pulmonx Corporation | $116.18 | 2019 | |
| Circassia INC. | $110.06 | 2019-2020 | |
| Genentech USA, INC. | $96.27 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $68.63 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $65.96 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $65.64 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $64.28 | 2019 | |
| Abbvie INC. | $63.54 | 2021-2022 | |
| Amgen INC. | $41.52 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ceribell, INC. | $41.16 | 2022 | |
| Insmed, INC. | $39.53 | 2019-2020 | |
| Genzyme Corporation | $34.22 | 2019-2020 | |
| Optinose US, INC. | $24.26 | 2020 | |
| Pfizer INC. | $23.70 | 2020 | |
| Mylan Specialty L.P. | $22.60 | 2021 | |
| Electromed, INC. | $19.46 | 2019 | |
| Abiomed | $19.44 | 2019 | |
| Gilead Sciences, INC. | $18.14 | 2019 | |
| United Therapeutics Corporation | $13.62 | 2020 | |
| Clovis Oncology, INC. | $12.23 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.61 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hany Ghali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.